What influences healthcare providers’ prescribing decisions? Results from a national survey
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (10) , 1770-1779
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration (HHSF223201510001B)
This publication has 42 references indexed in Scilit:
- The Role of the Medical Science Liaison in IndustryAORN Journal, 2010
- Factors Associated With Physicians’ Reliance on Pharmaceutical Sales RepresentativesAcademic Medicine, 2009
- Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic ReviewPLOS ONE, 2009
- Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?Journal of General Internal Medicine, 2009
- Key opinion leaders: where they come from and how that affects the drugs you prescribeDermatologic Therapy, 2009
- Medical science liaisons: A look to the futureJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2008
- The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United StatesPLOS Medicine, 2008
- The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industryAnnals of Oncology, 2007
- A National Survey of Physician–Industry RelationshipsNew England Journal of Medicine, 2007
- Accuracy of pharmaceutical advertisements in medical journalsThe Lancet, 2003